Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials


Dick A. D. , Tugal-Tutkun I. , Foster S., ZIERHUT M., LIEW S. H. M. , BEZLYAK V., ...More

OPHTHALMOLOGY, vol.120, no.4, pp.777-787, 2013 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 120 Issue: 4
  • Publication Date: 2013
  • Doi Number: 10.1016/j.ophtha.2012.09.040
  • Title of Journal : OPHTHALMOLOGY
  • Page Numbers: pp.777-787

Abstract

Purpose: To determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A blockade, in patients with noninfectious uveitis.